跳至主要内容
临床试验/NCT01727375
NCT01727375撤回不适用

Prevention of Delirium With Light in the Intensive Care Unit

Charite University, Berlin, Germany2 个研究点 分布在 1 个国家开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Prevalence of delirium

研究概览

简要总结

The purpose of this multicenter randomised controlled trial is to investigate if circadian light at the patients bedside (using Philips HealWell system, CE marked)significantly reduces prevalence of delirium in mechanically ventilated intensive care unit patients.

详细描述

Patients, who are randomly assigned to the "Lightening arm" will have the circadian light for the whole ICU stay. Light levels at the patients bedside will be measured continuously: embedded light sensors provide irradiance and luminous lux recordings in red, green, and blue color bands and a white light measurement in lux

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female patients with age 18 years and above
  • Intensive Care Unit stay ≥ 48 hours
  • Invasive mechanical ventilation or not invasive mechanical ventilation (with positive ventilation pressure >6hours/day and highflow >30 litres) on the day of Intensive Care Unit admission

排除标准

  • Patients with a history Intensive Care Unit stay during the actual hospital stay
  • Patients with delirium on the day of Intensive Care Unit admission
  • Patients with psychiatric diseases
  • Patients with a history of stroke and known cognitive dysfunctions
  • Participation in other clinical studies 10 days before study inclusion and during the study period
  • Psychiatric disease
  • History of stroke with known residual cognitive deficits
  • History of Asystolia or pulseless electric activity with cardiopulmonary resuscitation during entire hospital stay
  • Analphabetism
  • Unability of German language use
  • Anacusis or Hypoacusis with hearing aid device, Amaurosis
  • Allergies to any ingredient of the electrode fixing material
  • Lacking willingness to save and hand out data within the study
  • Accommodation in an institution due to an official or judicial order
  • The informed consent of the patient or the subject's legally acceptable representative can´t be obtained in time
  • Patient has a power of attorney or patient's provision, where he/she refuses participation in any clinical trial

结局指标

主要结局

Prevalence of delirium

时间窗: Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days

Dekirium will be measured with the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)

次要结局

  • Delirium prevalence(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Severity of delirium(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Duration of delirium(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Prevalence of subsyndromal delirium (SSD)(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Severity of anxiety(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Cognitive Dysfunction(ICU admission, ICU discharge, 6 months after hospital discharge, 12 months after ICU discharge)
  • Post-Traumatic Stress Disorder (PTSD)(6 and 12 months after hospital discharge)
  • Sleep quality(In the night, starting 48 hours after ICU admission)
  • ICU length of stay(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Duration of mechanical ventilation(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Hospital length of stay(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 4 weeks)
  • Pain level(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Level of sedation(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Amount of administered opioids(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Amount of administered benzodiazepines(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Amount of administered sedatives(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Amount of administered antipsychotics(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Mortality(ICU discharge, hospital discharge, 6 months after hospital discharge, 12 months after hospital discharge)
  • Light levels (lux) Light levels (lux)(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Light frequencies(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)
  • Noise levels (decibel)(Participants will be followed for the duration of Intensive Care Unit stay, an expected average of 5 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Claudia Spies

Univ.-Prof. Dr. Claudia Spies

Charite University, Berlin, Germany

研究点 (2)

Loading locations...

相似试验